东华测试（300354）：2025Q3收入恢复高增长，人形机器人业务拓展有望提速

Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Insights - The company reported a significant revenue increase in Q3 2025, primarily benefiting from order acceptance and a low base from the previous year. The revenue for the first three quarters of 2025 reached 385 million, a year-on-year increase of 8.70%. In Q3 2025 alone, revenue was 102 million, up 30.75% year-on-year [2][6]. - The company is actively promoting domestic substitution of mechanical products and is building a high-end scientific research instrument platform. It is also expanding into the sensor industry and accelerating its layout in the humanoid robot sector through strategic partnerships [2][6]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a net profit of 101 million, a year-on-year increase of 2.23%. The net profit for Q3 2025 was 25 million, up 0.50% year-on-year. The net profit excluding non-recurring items for the same period was 99 million, a slight increase of 0.11% [6]. - The gross profit margin for the first three quarters of 2025 was 67.46%, an increase of 0.91 percentage points year-on-year, while the net profit margin was 26.10%, a decrease of 1.71 percentage points year-on-year [12]. Business Development - The company is focusing on the domestic substitution of mechanical products and is developing new products such as customized measurement and control analysis systems. It is also enhancing its sensor product line, which includes various types of sensors suitable for harsh environments [12]. - The company has accelerated its entry into the humanoid robot industry, signing a strategic cooperation agreement with Nantong Zhenkang and engaging in strategic discussions with Nidec to collaborate on testing and verification in the field of precision transmission products [12]. Future Outlook - The company is expected to achieve a net profit of 159 million and 206 million in 2025 and 2026, respectively, corresponding to price-to-earnings ratios of 39x and 30x. The "Buy" rating is maintained based on these projections [12].